323 related articles for article (PubMed ID: 17492285)
21. An improved method of 18F peptide labeling: hydrazone formation with HYNIC-conjugated c(RGDyK).
Lee YS; Jeong JM; Kim HW; Chang YS; Kim YJ; Hong MK; Rai GB; Chi DY; Kang WJ; Kang JH; Lee DS; Chung JK; Lee MC; Suh YG
Nucl Med Biol; 2006 Jul; 33(5):677-83. PubMed ID: 16843843
[TBL] [Abstract][Full Text] [Related]
22. 18F-FPRGD2 PET/CT imaging of integrin αvβ3 in renal carcinomas: correlation with histopathology.
Withofs N; Signolle N; Somja J; Lovinfosse P; Nzaramba EM; Mievis F; Giacomelli F; Waltregny D; Cataldo D; Gambhir SS; Hustinx R
J Nucl Med; 2015 Mar; 56(3):361-4. PubMed ID: 25655629
[TBL] [Abstract][Full Text] [Related]
23. (64)Cu labeled AmBaSar-RGD2 for micro-PET imaging of integrin αvβ3 expression.
Cai H; Li Z; Huang CW; Park R; Conti PS
Curr Radiopharm; 2011 Jan; 4(1):68-74. PubMed ID: 22191616
[TBL] [Abstract][Full Text] [Related]
24. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.
Zhang X; Cai W; Cao F; Schreibmann E; Wu Y; Wu JC; Xing L; Chen X
J Nucl Med; 2006 Mar; 47(3):492-501. PubMed ID: 16513619
[TBL] [Abstract][Full Text] [Related]
25. MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide.
Chen X; Park R; Tohme M; Shahinian AH; Bading JR; Conti PS
Bioconjug Chem; 2004; 15(1):41-9. PubMed ID: 14733582
[TBL] [Abstract][Full Text] [Related]
26. Impact of bifunctional chelators on biological properties of 111In-labeled cyclic peptide RGD dimers.
Shi J; Kim YS; Chakraborty S; Zhou Y; Wang F; Liu S
Amino Acids; 2011 Nov; 41(5):1059-70. PubMed ID: 20052508
[TBL] [Abstract][Full Text] [Related]
27. Preparation and characterization of 99mTc(CO)3-BPy-RGD complex as alphav beta3 integrin receptor-targeted imaging agent.
Zhang X; Chen X
Appl Radiat Isot; 2007 Jan; 65(1):70-8. PubMed ID: 17011200
[TBL] [Abstract][Full Text] [Related]
28. Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene.
Xiong Z; Cheng Z; Zhang X; Patel M; Wu JC; Gambhir SS; Chen X
J Nucl Med; 2006 Jan; 47(1):130-9. PubMed ID: 16391197
[TBL] [Abstract][Full Text] [Related]
29. Imaging integrin αvβ 3 and NRP-1 positive gliomas with a novel fluorine-18 labeled RGD-ATWLPPR heterodimeric peptide probe.
Wu H; Chen H; Pan D; Ma Y; Liang S; Wan Y; Fang Y
Mol Imaging Biol; 2014 Dec; 16(6):781-92. PubMed ID: 25001194
[TBL] [Abstract][Full Text] [Related]
30. Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides.
Dijkgraaf I; Kruijtzer JA; Liu S; Soede AC; Oyen WJ; Corstens FH; Liskamp RM; Boerman OC
Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):267-73. PubMed ID: 16909226
[TBL] [Abstract][Full Text] [Related]
31. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Janssen ML; Oyen WJ; Dijkgraaf I; Massuger LF; Frielink C; Edwards DS; Rajopadhye M; Boonstra H; Corstens FH; Boerman OC
Cancer Res; 2002 Nov; 62(21):6146-51. PubMed ID: 12414640
[TBL] [Abstract][Full Text] [Related]
32. 68Ga-NODAGA-RGDyK for αvβ3 integrin PET imaging. Preclinical investigation and dosimetry.
Buchegger F; Viertl D; Baechler S; Dunet V; Kosinski M; Poitry-Yamate C; Rüegg C; Prior JO
Nuklearmedizin; 2011; 50(6):225-33. PubMed ID: 21989840
[TBL] [Abstract][Full Text] [Related]
33. An engineered knottin peptide labeled with 18F for PET imaging of integrin expression.
Miao Z; Ren G; Liu H; Kimura RH; Jiang L; Cochran JR; Gambhir SS; Cheng Z
Bioconjug Chem; 2009 Dec; 20(12):2342-7. PubMed ID: 19908826
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of two novel ⁶⁴Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ₃.
Hernandez R; Czerwinski A; Chakravarty R; Graves SA; Yang Y; England CG; Nickles RJ; Valenzuela F; Cai W
Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1859-68. PubMed ID: 26016906
[TBL] [Abstract][Full Text] [Related]
35. Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide.
Dijkgraaf I; Liu S; Kruijtzer JA; Soede AC; Oyen WJ; Liskamp RM; Corstens FH; Boerman OC
Nucl Med Biol; 2007 Jan; 34(1):29-35. PubMed ID: 17210459
[TBL] [Abstract][Full Text] [Related]
36. Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers.
Wang L; Shi J; Kim YS; Zhai S; Jia B; Zhao H; Liu Z; Wang F; Chen X; Liu S
Mol Pharm; 2009; 6(1):231-45. PubMed ID: 19067525
[TBL] [Abstract][Full Text] [Related]
37. Dual integrin and gastrin-releasing peptide receptor targeted tumor imaging using 18F-labeled PEGylated RGD-bombesin heterodimer 18F-FB-PEG3-Glu-RGD-BBN.
Liu Z; Yan Y; Chin FT; Wang F; Chen X
J Med Chem; 2009 Jan; 52(2):425-32. PubMed ID: 19113865
[TBL] [Abstract][Full Text] [Related]
38. Novel (64)Cu- and (68)Ga-labeled RGD conjugates show improved PET imaging of α(ν)β(3) integrin expression and facile radiosynthesis.
Dumont RA; Deininger F; Haubner R; Maecke HR; Weber WA; Fani M
J Nucl Med; 2011 Aug; 52(8):1276-84. PubMed ID: 21764795
[TBL] [Abstract][Full Text] [Related]
39. A comparison of [
Liu N; Wan Q; Wu X; Zhao T; Jakobsson V; Yuan H; Chen X; Zhang J; Zhang W
Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1685-1697. PubMed ID: 38246909
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
